Condition
C.Delivery; Surgery (Previous), Gynecological
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Unknown3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02194855Phase 4CompletedPrimary
Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis
NCT02619578Not ApplicableCompletedPrimary
The Effect of TEAS on the Quality of Early Recovery
NCT02604797Not ApplicableUnknownPrimary
Analgesia Effects of Nalbuphine vs Sulfentanil
NCT02595333Not ApplicableUnknownPrimary
Incision Pain and Uterine Contraction Pain After Cesarean Section
NCT02554175Not ApplicableUnknownPrimary
The Effective Effect-Site Propofol Concentration for Induction and Intubation for Schnider Model in Parturients
Showing all 5 trials